SCHEMBL6369128

SCHEMBL6369128

CC(C)(C)OC(=O)C1(C(=O)OC(C)(C)C)Cc2cc(/C=C/C(=O)O)ccc2O1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.44
▸ ALOX5 P09917 2/20 0.42
▸ HDAC1 Q13547 4/20 0.42
▸ HSD17B10 Q99714 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ THRB P10828 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ CA12 O43570 3/20 0.38
▸ CA1 P00915 3/20 0.38
▸ CA2 P00918 3/20 0.38
▸ CA3 P07451 3/20 0.38
▸ CA4 P22748 3/20 0.38
▸ CA6 P23280 3/20 0.38
▸ CA5A P35218 3/20 0.38
▸ CA7 P43166 3/20 0.38
▸ CA9 Q16790 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6369131 1.00 KDM4E (0.44) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL6369134 0.95 KDM4E (0.42) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL7597289 0.82 KDM4E (0.52) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL7597293 0.82 KDM4E (0.52) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL9101771 0.77 KDM4E (0.52) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL9101781 0.77 KDM4E (0.52) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL29999634 0.72 KDM4E (0.49) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL14898033 0.70 KDM4E (0.50) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL4283078 0.69 THRB (0.56) KDM4EALOX5HDAC1HSD17B10ALDH1A1
SCHEMBL4283080 0.69 THRB (0.56) KDM4EALOX5HDAC1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050101540-A1 STAT modulators AMGEN INC. (US) 2005-05-12 — — US disclosed
US-6884782-B2 STAT modulators AMGEN INC. (US) 2005-04-26 — — US disclosed
US-20020151504-A1 STAT modulators TULARIK INC. 2002-10-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151504-A1 STAT modulators STAT6, STAT4, STAT3 KDM4E 688/4885ALOX5 2337/4885HDAC1 242/4885
US-20050101540-A1 STAT modulators STAT6, STAT4, STAT3 KDM4E 688/4885ALOX5 2337/4885HDAC1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback